Delivering a Diuretic Into the Liver Artery Followed by Plugging up the Artery to Starve Out Liver Cancer Cells
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Unresectable Hepatocellular Carcinoma
Related studies linked through entity extraction aliases.
Sorafenib and Bavituximab Plus SBRT in Unresectable Hepatocellular Carcinoma
- Status
- WITHDRAWN
- Phase
- PHASE1
TACE Study-Liver Embolization Perfusion (VGH Radiology LIU)
- Status
- COMPLETED
- Phase
- N/A
Ph 2 Trial of ADI PEG 20 Plus Concurrent Transarterial Chemoembolization (TACE) Vs TACE Alone in Patients With Unresectable Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Sorafenib Tosylate and Yttrium Y 90 Glass Microspheres in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy Evaluation of TheraSphere in Patients With Inoperable Liver Cancer
- Status
- COMPLETED
- Phase
- NA
Transcatheter Arterial Chemoembolization Therapy In Combination With Sorafenib
- Status
- UNKNOWN
- Phase
- PHASE2
Yttrium Y 90 Glass Microspheres in Treating Patients With Unresectable Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- NA
Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Chemoembolization With or Without Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery
- Status
- COMPLETED
- Phase
- PHASE3
Trial of ARQ 197 in Patients With Unresectable Hepatocellular Carcinoma (HCC) Who Have Failed One Prior Systemic Therapy
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Research of Licartin Combined With TACE in the Treatment of Unresectable Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE4
An International Phase 2 Study Of SU011248 In Patients With Inoperable Liver Cancer
- Status
- COMPLETED
- Phase
- PHASE2